Search

everythinglearnresearchcommunity

for

Search:↓

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Both mouse and rat models are effective for testing alopecia areata treatments.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

FOXN1 gene variants cause low T cells and immune issues from birth.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

DNA methylation changes are linked to hair growth cycles in goats.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

CD90 is present on specific cells in dog hair follicles.

Low-Level Light Therapy is effective for skin rejuvenation, wound healing, and hair growth, with mild side effects.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.